Ontology highlight
ABSTRACT: The NLRP3 inflammasome is critical for host defense against bacterial infection and is involved in the pathogenesis of various inflammatory diseases. The aggregation of its sensor protein NLRP3 is a pivotal checkpoint for inflammasome activation. However, the regulatory mechanism of NLRP3 aggregation is not completely understood. Here, we identify the metabolic enzyme ATP-citrate lyase (ACLY) as a direct binding partner that constrains NLRP3 aggregation, membrane translocation and activation. We demonstrate that ACLY interacts with the NLRP3-PYD independently of its enzymatic function, thereby sterically hindering NLRP3 aggregation and suppressing inflammasome assembly. Paradoxically, we find that NLRP3 binding to ACLY inhibits ACLY’s enzymatic activity and remodels cellular metabolism, which counteracts the stimulatory effect of ACLY on NLRP3 inflammasome activation. This reciprocal interaction reveals an essential role of ACLY as a brake for NLRP3 aggregation, and also establishes NLRP3 as a metabolic checkpoint to regulate ACLY-mediated metabolism. Furthermore, we develop a peptide that disrupts the ACLY-NLRP3 interaction and promotes NLRP3 inflammasome activation, which enhances host defense against bacterial infection. Our work delineates a self-limiting circuit for immunometabolic crosstalk, positioning the ACLY-NLRP3 axis as a new therapeutic target for inflammasome-driven pathologies.
INSTRUMENT(S): Liquid Chromatography MS - positive - hilic, Liquid Chromatography MS - alternating - reverse-phase
PROVIDER: MTBLS13400 | MetaboLights | 2026-01-07
REPOSITORIES: MetaboLights
Items per page: 5 1 - 5 of 6 |